AKBA
AKBA clinical trials: Akebia Therapeutics, Inc.
Every trial on ClinicalTrials.gov where Akebia Therapeutics, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 43
- Trials linked
- 37
- As lead sponsor
- 6
- As collaborator
- 1
- Primary completions as lead sponsor, next 90 days
AKBA on the catalyst calendar · AKBA registry changes
- Primary completion Aug 12, 2026ActualPhase 3NCT06901505To Evaluate the Efficacy of Three Times Weekly (TIW) Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD...Akebia Therapeutics · Anemia of Chronic Kidney DiseaseCompletedAKBALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2027Sponsor estimatePhase 2NCT07268638A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)Akebia Therapeutics · Focal Segmental GlomerulosclerosisRecruitingAKBALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2026Sponsor estimatePhase 1NCT07429006SAD and MAD Study of AKB-9090 in Healthy Adult ParticipantsAkebia Therapeutics · Healthy VolunteersRecruitingAKBALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2028Sponsor estimatePhase 2NCT06419205A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3GAkebia Therapeutics · IgA NephropathyRecruitingAKBALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2026Sponsor estimatePhase 3NCT05082584Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease Naive to...Akebia Therapeutics · Anemia of Chronic Kidney DiseaseWithdrawnAKBALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2026Sponsor estimatePhase 3NCT05082571Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney DiseaseAkebia Therapeutics · Anemia of Chronic Kidney DiseaseWithdrawnAKBALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 26, 2021ActualPhase 3NCT04313153Trial Evaluating the Efficacy and Safety of Oral Vadadustat Once Daily (QD) and Three Times Weekly (TIW) for the Maintenance Treatment...Akebia Therapeutics · AnemiaCompletedAKBALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 6, 2023ActualPhase 3NCT04707768Study Evaluating the Efficacy and Safety of Dose Conversion From a Long-acting Erythropoiesis-stimulating Agent (Mircera®) to Three...Akebia Therapeutics · Anemia Associated With Chronic Kidney Disease (CKD)CompletedAKBALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 5, 2020ActualPhase 2NCT03799627Study of Vadadustat in Hemodialysis Participants With Anemia Switching From Epoetin AlfaAkebia Therapeutics · AnemiaCompletedAKBALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 19, 2019ActualPhase 2NCT03254485A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)Akebia Therapeutics · Heart Failure With Preserved Ejection FractionCompletedAKBALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 20, 2019ActualPhase 2NCT03217591A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured...Akebia Therapeutics · Type 2 Diabetes Mellitus With Diabetic NephropathyCompletedAKBALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 31, 2020ActualPhase 3NCT02865850Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Participants With Incident...Akebia Therapeutics · AnemiaCompletedAKBALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 3, 2014ActualPhase 2NCT0190648920-Week Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and AnemiaAkebia Therapeutics · AnemiaCompletedAKBALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 24, 2010ActualPhase 2NCT04707573Study to Assess the Safety and Pharmacokinetics of AKB-6548 in Participants With Chronic Kidney Disease (CKD), Stages 3 and 4Akebia Therapeutics · Chronic Kidney DiseaseCompletedAKBALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 16, 2020ActualPhase 3NCT02892149Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Dialysis-dependent Chronic...Akebia Therapeutics · AnemiaCompletedAKBALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 18, 2020ActualPhase 3NCT02680574Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Non-dialysis-dependent...Akebia Therapeutics · AnemiaCompletedAKBALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 4, 2020ActualPhase 3NCT02648347Study to Evaluate Vadadustat for the Correction of Anemia in Participants With Non-dialysis-dependent Chronic Kidney DiseaseAkebia Therapeutics · AnemiaCompletedAKBALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 22, 2015ActualPhase 2NCT0226019316-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Participants With End Stage Renal Disease (ESRD) Requiring Chronic HemodialysisAkebia Therapeutics · AnemiaCompletedAKBALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 16, 2012ActualPhase 2NCT0138109442-Day Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and AnemiaAkebia Therapeutics · AnemiaCompletedAKBALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 13, 2011ActualPhase 2NCT01235936Safety and Efficacy Study for AKB-6548 in Participants With Chronic Kidney Disease and AnemiaAkebia Therapeutics · AnemiaCompletedAKBALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 24, 2017ActualPhase 2NCT03054350Dose-Finding Study of Vadadustat in Japanese Subjects With Anemia Secondary to Dialysis-Dependent Chronic Kidney Disease (DD-CKD)Akebia Therapeutics · AnemiaCompletedAKBALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 4, 2017ActualPhase 2NCT03054337Dose-Finding Study of Vadadustat in Japanese Subjects With Anemia Secondary to Non-Dialysis Dependent Chronic Kidney Disease (NDD-CKD)Akebia Therapeutics · AnemiaCompletedAKBALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 21, 2018ActualPhase 2NCT03140722Study to Evaluate Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Who Are Hyporesponsive to...Akebia Therapeutics · AnemiaTerminatedAKBALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2, 2020ActualPhase 1NCT04299633Study in Healthy Adult Subjects to Assess the Effect of Phosphate Binders on the Pharmacokinetics of a Single Dose of VadadustatAkebia Therapeutics · Healthy VolunteersCompletedAKBALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 5, 2020ActualPhase 1NCT03992066Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Hemodialysis Subjects With Anemia Associated With...Akebia Therapeutics · Anemia Associated With Chronic Kidney DiseaseCompletedAKBALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 25 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerShowing the first 25 trials. There are 18 more in this window; the full list is part of TrialScanner.
Unlock with TrialScanner